March 23 (Reuters) -
GILEAD NEARS UP TO $2BN DEAL FOR AUTOIMMUNE BIOTECH OURO MEDICINES - FT
GILEAD WILL PAY PRIVATELY HELD OURO’S INVESTORS ROUGHLY $1.5BN UPFRONT IN CASH AND AT LEAST EXTRA $500MN IF CERTAIN CLINICAL TRIAL MILESTONES ARE HIT - FT
TALKS BETWEEN GILEAD AND OURO MEDICINES ARE AT AN ADVANCED STAGE AND A DEAL COULD BE ANNOUNCED IN THE COMING DAYS - FT
Source text: https://tinyurl.com/3jye8yjx
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))